Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Joan A, Barberá"'
Autor:
Alfredo Guillén-Del-Castillo, Manuel López Meseguer, Vicent Fonollosa-Pla, Berta Sáez Giménez, Dolores Colunga-Argüelles, Eva Revilla-López, Manuel Rubio-Rivas, Maria Jose Cristo Ropero, Ana Argibay, Joan Albert Barberá Mir, Xavier Pla Salas, Amaya Martínez Meñaca, Ana Belén Madroñero Vuelta, Antonio Lara Padrón, Luis Sáez Comet, Juan Antonio Domingo Morera, Cristina González-Echávarri, Teresa Mombiela, Norberto Ortego-Centeno, Manuela Marín González, Carles Tolosa-Vilella, Isabel Blanco, Pilar Escribano Subías, Carmen Pilar Simeón-Aznar, RESCLE Consortium, REHAP Consortium
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract To assess severity markers and outcomes of patients with systemic sclerosis (SSc) with or without pulmonary arterial hypertension (PAH-SSc/non-PAH-SSc), and the impact of interstitial lung disease (ILD) on PAH-SSc. Non-PAH-SSc patients from
Externí odkaz:
https://doaj.org/article/dbfcb5791dff4a5388fa75db31fa8f36
Autor:
Alfredo Guillén-Del-Castillo, Manuel López Meseguer, Vicent Fonollosa-Pla, Berta Sáez Giménez, Dolores Colunga-Argüelles, Eva Revilla-López, Manuel Rubio-Rivas, Maria Jose Cristo Ropero, Ana Argibay, Joan Albert Barberá, Xavier Pla Salas, Amaya Martínez Meñaca, Ana Belén Madroñero Vuelta, Antonio Lara Padrón, Luis Sáez Comet, Juan Antonio Domingo Morera, Cristina González-Echávarri, Teresa Mombiela, Norberto Ortego-Centeno, Manuela Marín González, Carles Tolosa-Vilella, Isabel Blanco, Pilar Escribano Subías, Carmen Pilar Simeón-Aznar, RESCLE Consortium, REHAP Consortium
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/3de8cdeae3bb458dae6e4c1c0be7576f
Autor:
Vallerie V. McLaughlin, Pavel Jansa, Jens E. Nielsen-Kudsk, Michael Halank, Gérald Simonneau, Ekkehard Grünig, Silvia Ulrich, Stephan Rosenkranz, Miguel A. Gómez Sánchez, Tomás Pulido, Joanna Pepke-Zaba, Joan Albert Barberá, Marius M. Hoeper, Jean-Luc Vachiéry, Irene Lang, Francine Carvalho, Christian Meier, Katharina Mueller, Sylvia Nikkho, Andrea M. D’Armini
Publikováno v:
BMC Pulmonary Medicine, Vol 17, Iss 1, Pp 1-9 (2017)
Abstract Background Following positive results from the Phase III CHEST-1 study in patients with inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH), the Phase IIIb CTEPH early access study (EAS) was designed to a
Externí odkaz:
https://doaj.org/article/e4409de6829f4829bf3c1080ab58ca37
Autor:
Daniel Morales-Cano, Bianca Barreira, Beatriz De Olaiz Navarro, María Callejo, Gema Mondejar-Parreño, Sergio Esquivel-Ruiz, Jose A. Lorente, Laura Moreno, Joan A. Barberá, Ángel Cogolludo, Francisco Perez-Vizcaino
Publikováno v:
Antioxidants, Vol 10, Iss 2, p 155 (2021)
Current approved therapies for pulmonary hypertension (PH) aim to restore the balance between endothelial mediators in the pulmonary circulation. These drugs may exert vasodilator effects on poorly oxygenated vessels. This may lead to the derivation
Externí odkaz:
https://doaj.org/article/27829e363cb446dab0054b648119231b
Autor:
Virginia Chamorro, Daniel Morales-Cano, Javier Milara, Bianca Barreira, Laura Moreno, María Callejo, Gema Mondejar-Parreño, Sergio Esquivel-Ruiz, Julio Cortijo, Ángel Cogolludo, Joan A Barberá, Francisco Perez-Vizcaino
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0191239 (2018)
Current treatment with vasodilators for pulmonary hypertension associated with respiratory diseases is limited by their inhibitory effect on hypoxic pulmonary vasoconstriction (HPV) and uncoupling effects on ventilation-perfusion (V'/Q'). Hypoxia is
Externí odkaz:
https://doaj.org/article/2c7850a444eb4281b23240a9aa12e1f2
Autor:
Ana, García-Álvarez, Isabel, Blanco, Inés, García-Lunar, Paloma, Jordà, Juan J, Rodriguez-Arias, Leticia, Fernández-Friera, Isabel, Zegri, Jorge, Nuche, Manuel, Gomez-Bueno, Susanna, Prat, Sandra, Pujadas, Eduard, Sole-Gonzalez, Maria D, Garcia-Cossio, Mercedes, Rivas, Estefanía, Torrecilla, Daniel, Pereda, Javier, Sanchez, Pablo, García-Pavía, Javier, Segovia-Cubero, Juan F, Delgado, Sonia, Mirabet, Valentín, Fuster, Joan A, Barberá, Borja, Ibañez
Publikováno v:
European journal of heart failureReferences.
Pulmonary hypertension (PH) associated with left heart disease is an increasingly prevalent problem, orphan of targeted therapies, and related to a poor prognosis, particularly when pre- and post-capillary PH combine. The current study aimed to deter
Autor:
Pablo Aldaz Herce, Carme Batalla Martínez, Eva Comín Bertrán, José Javier Gómez Marco, Silvia Gómez Roig, Susana Martín Martín, María Luisa Morató Agustí, Joan Puig Barberá, Germán Schwarz
Publikováno v:
Atención Primaria, Vol 46, Iss S4, Pp 42-58 (2014)
Externí odkaz:
https://doaj.org/article/5ba1fefa1eb9402bab848df0226b8bd4
Autor:
Renata Bujak, Jesús Mateo, Isabel Blanco, José Luis Izquierdo-García, Danuta Dudzik, Michał J Markuszewski, Victor Ivo Peinado, Martín Laclaustra, Joan Albert Barberá, Coral Barbas, Jesús Ruiz-Cabello
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0160505 (2016)
Diagnosis of pulmonary arterial hypertension (PAH) is difficult due to the lack of specific clinical symptoms and biomarkers, especially at early stages. We compared plasma metabolic fingerprints of PAH patients (n = 20) with matched healthy voluntee
Externí odkaz:
https://doaj.org/article/ebdf0571c8d847fd9e9daa2d2b0d1dd0
Autor:
María Lázaro, Salvador, Luis, Rodríguez-Padial, Clara, Soto Abánades, Alejandro, Cruz Utrilla, Joan Albert, Barberá Mir, Manuel, López-Meseguer, Javier, Segovia Cubero, Gustavo Juan, Samper, Isabel, Blanco Vich, Pilar, Escribano-Subías
Publikováno v:
Journal of internal medicineReferences. 292(1)
Pulmonary arterial hypertension (PAH) is an independent predictor of death in patients with human immunodeficiency virus (HIV) infection. HIV is the leading cause of PAH (HIV-PAH) worldwide.We described the characteristics, treatment patterns, and pr
Publikováno v:
In Revista Española de Cardiología (English Edition) 2010 63(5):583-596